Benefits of Outsourcing Formulation Development & Manufacturing to Almac
What formulation development and manufacturing services do Almac Pharma Services offer?
Almac Pharma Services is an established CDMO with a focus on oral dose formulations. With full regulatory approved manufacturing facilities, we specialise in the development and manufacture of tablets, mini tablets, powders and capsules, from small scale in support of clinical supplies, or orphan and niche drug products to large scale commercial manufacture and packaging.
What sets us apart from competitors?
We are an established, reliable and trusted CDMO offering a full range of services, including pre-formulation studies, process development, scale-up, validation, product launch and ongoing commercial supply. This means we can provide fully integrated tailored solutions from a flexible single platform. We place a strong emphasis on quality and consistency, with a commitment to being able to solve complex formulation and manufacturing challenges and provide clients with a diverse and skilled team of experts. Our wide range of technologies paired with our deep expertise and world class project management also sets us apart from our competitors.
What is the benefit of a single source provider to a client?
As Almac provides a single service offering, we can integrate from API development, formulation development and manufacture, to clinical studies and on through to commercial supply. A client has the ability to move their unique drug product through its entire lifecycle using one single source, enabling Almac to continuously share knowledge between teams, resulting in complex development and manufacturing challenges being met with solutions based on learned product knowledge. Clients also benefit from reduced time and costs associated with managing multiple service providers.
Almac Group’s range of innovative, integrated solutions:
What influences Almac Pharma Services’ investments into technology and capabilities?
Careful consideration and full understanding of the needs of our clients is a driving force behind our facility, resource and technology investments. Close monitoring of research and development pipelines and industry trends also enables us to make key investment decisions and offer proactive solutions to meet forecast demand. By offering state-of-the-art and diverse capabilities, we enable clients to engage with us throughout their development process. This alleviates the need for them to purchase expensive equipment, especially for small development batches, and also the need to increase labour costs by adding additional staff. Partnering with an experienced CDMO from the onset to manage all development milestones can provide benefits related to cost saving, quality control, flexibility, expertise, streamlined processes, and enable pharmaceutical companies to focus on their core strengths of bringing much needed treatment options to patients in need.
Visit our Pharmaceutical Drug Product Development page to find out more about our development and manufacturing capabilities.
